COVID-19 Disease and Coagulopathy: Assessment of Clotting Factor Levels in Patients With SARS-CoV-2 Infection

University Hospital, Ioannina

Status: Completed

Conditions: SARS-COV2 Infection; Hospitalized Patients; COVID-19 Disease

Treatments: Drug: low molecular weight Heparin as standard of care treatment

Study type: Observational

Funder types: Other

Identifiers

NCT04787510

895/23-12-2020

Details and patient eligibility

About

Effect of Covid-19 disease in clotting factors levels in hospitalized patients

Full description

Effect of Covid-19 disease in clotting factors levels in hospitalized patients positive for sars-cov2 infection.

Association between clotting factors levels and disease severity,morbidity and mortality in these patients.

Effect of anticoagulant therapy in the clotting factors' levels in these patients

Enrollment: 50 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• AGE> 18
• SINGED INFORMED CONSENT FORM
• POSITIVE PCR TEST FOR SARS-COV2 INFECTION
• FINDINGS IN CXR OR CT OF THE LUNGS CONSISTENT WITH INFECTION OF LOWER RESPIRATORY TRACT

Exclusion criteria

• AGE<18
• DENIAL TO PROVIDE INFORMED CONSENT FORM
• HISTORY OF MALIGNANCY
• PRIOR USE OF ANTICOAGULANT THERAPY
• PRIOR USE OF STEROIDS LONGER THAN 14 DAYS
• LACTATION-PREGNANCY